39 minutes ago
New real world data suggest GLP-1 RAs do not drive DKA or pancreatitis risk in adult patients with type 1 diabetes and may reduce hospital admissions.
1 hour ago
Shah discusses the potential of GLP-1 receptor agonists as adjunctive therapy in type 1 diabetes, from glycemic control to cardiometabolic risk.
2 hours ago
Mechanick discusses the importance of dietary interventions in endocrinology and highlights the need for further education and awareness of metabolic function.
3 hours ago
In this segment of the interview, questions remaining about AI's effectiveness among patients in dermatology were explored.
4 hours ago
Galindo describes how CKM may transform diabetes care by enabling real-time insights, improving DKA prevention, and advancing metabolic understanding.